|
STRN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.52216042390319E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69779967862382E-10 |
| Normal-vs-Stage2 |
6.0810999999994E-05 |
| Normal-vs-Stage3 |
1.52599999303504E-09 |
| Normal-vs-Stage4 |
9.51609901989059E-11 |
| Stage1-vs-Stage2 |
5.091200E-01 |
| Stage1-vs-Stage3 |
2.109400E-01 |
| Stage1-vs-Stage4 |
1.502440E-02 |
| Stage2-vs-Stage3 |
1.717430E-01 |
| Stage2-vs-Stage4 |
1.427710E-02 |
| Stage3-vs-Stage4 |
2.047200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09321449062827E-12 |
| Normal-vs-AfricanAmerican |
6.883700E-03 |
| Normal-vs-Asian |
4.4425000012005E-08 |
| Caucasian-vs-AfricanAmerican |
9.778100E-02 |
| Caucasian-vs-Asian |
7.175200E-01 |
| AfricanAmerican-vs-Asian |
8.089800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40329969866571E-10 |
| Normal-vs-Female |
4.66999772186227E-11 |
| Male-vs-Female |
5.012600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.83829995670237E-09 |
| Normal-vs-Age(41-60Yrs) |
2.97309954433445E-10 |
| Normal-vs-Age(61-80Yrs) |
5.85479997816662E-10 |
| Normal-vs-Age(81-100Yrs) |
1.568370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.811400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.590200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.989000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.961200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.879600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.272600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.248300E-02 |
| Classical-VS-Follicular |
3.007200E-01 |
| Classical-VS-Other |
4.533600E-01 |
| Classical-VS-Normal |
4.69989602791543E-11 |
| Tall-VS-Follicular |
1.634130E-02 |
| Tall-VS-Other |
6.677800E-01 |
| Tall-VS-Normal |
3.96820000192477E-08 |
| Follicular-VS-Other |
3.410400E-01 |
| Follicular-VS-Normal |
3.75180000000697E-05 |
| Other-VS-Normal |
4.223300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.91479967834607E-10 |
| Normal-vs-N1 |
4.76329997667335E-09 |
| N0-vs-N1 |
2.644800E-01 |
|
|
